专注于瘤,它是头癌患者的微环境免疫成员
Saim Pamuk1, Baris Ertugrul2, Goksu Kasarci3
1Department of Otorhinolaryngology & Head and Neck Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Pathology, research and practice
|September 5, 2024
概括
头支状细胞癌 (HNSCC) 中的免疫基因表达在瘤和周围组织之间有所不同. 这些免疫标记与吸烟和淋巴结参与等临床因素相关.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 瘤微环境 (TM) 在头部和部状细胞癌 (HNSCC) 的进展中起着至关重要的作用.
- 了解TM中的免疫细胞透和功能对于开发向疗法至关重要.
研究的目的:
- 为了比较HNSCC患者的TM中的免疫相关基因表达水平.
- 研究基因表达与临床特征之间的关联.
主要方法:
- 使用定量实时PCR (qRT-PCR) 来确定CD163,CD274,CD86,FUT4,FOXP3和ITGAX的表达.
- 从76名HNSCC患者的瘤组织和相邻周围组织中分析了基因表达水平.
- 表达式数据与患者的人口统计和临床数据相关.
主要成果:
- 与周围组织相比,CD163,CD274,FUT4和FOXP3在瘤组织中表达明显更高.
- 在淋巴结参与的患者中,FUT4表达升高.
- 在重度吸烟者中,CD86表达率较低,CD163,CD274和FUT4表达率随着外延伸 (ENE) 增加.
结论:
- 在HNSCC瘤微环境中的免疫标记表达的改变与特定的临床表现有关.
- 这些发现突出了HNSCC预后和治疗反应的潜在生物标志物.
更多相关视频
08:32Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
9.6K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493